Viewing StudyNCT04168931



Ignite Creation Date: 2024-05-06 @ 1:55 PM
Last Modification Date: 2024-10-26 @ 1:22 PM
Study NCT ID: NCT04168931
Status: TERMINATED
Last Update Posted: 2023-01-17
First Post: 2019-11-05

Brief Title: Trastuzumab to Patients With Advanced Gastric Cancer With HER2 Positive Expression in CTC
Sponsor: AC Camargo Cancer Center
Organization: AC Camargo Cancer Center

Conditions & Keywords Data

Conditions:
Name
Gastric Cancer Stage IV
Keywords:
Name View
gastric cancer View
HER2 View
trastuzumab View
circulating tumor cells View